THTX vs. RZLT, OMER, AKBA, IMMP, ACRV, FBLG, GBIO, OVID, XBIT, and ME
Should you be buying Theratechnologies stock or one of its competitors? The main competitors of Theratechnologies include Rezolute (RZLT), Omeros (OMER), Akebia Therapeutics (AKBA), Immutep (IMMP), Acrivon Therapeutics (ACRV), FibroBiologics (FBLG), Generation Bio (GBIO), Ovid Therapeutics (OVID), XBiotech (XBIT), and 23andMe (ME). These companies are all part of the "pharmaceutical preparations" industry.
Theratechnologies (NASDAQ:THTX) and Rezolute (NASDAQ:RZLT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability, community ranking and media sentiment.
In the previous week, Rezolute had 2 more articles in the media than Theratechnologies. MarketBeat recorded 2 mentions for Rezolute and 0 mentions for Theratechnologies. Theratechnologies' average media sentiment score of 1.00 beat Rezolute's score of 0.52 indicating that Theratechnologies is being referred to more favorably in the media.
Rezolute has a net margin of 0.00% compared to Theratechnologies' net margin of -23.04%. Theratechnologies' return on equity of 0.00% beat Rezolute's return on equity.
Rezolute has a consensus target price of $9.67, indicating a potential upside of 89.91%. Given Rezolute's higher probable upside, analysts clearly believe Rezolute is more favorable than Theratechnologies.
83.0% of Rezolute shares are owned by institutional investors. 20.8% of Rezolute shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Theratechnologies has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500. Comparatively, Rezolute has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500.
Theratechnologies has higher revenue and earnings than Rezolute. Rezolute is trading at a lower price-to-earnings ratio than Theratechnologies, indicating that it is currently the more affordable of the two stocks.
Rezolute received 28 more outperform votes than Theratechnologies when rated by MarketBeat users. Likewise, 76.00% of users gave Rezolute an outperform vote while only 52.73% of users gave Theratechnologies an outperform vote.
Summary
Theratechnologies and Rezolute tied by winning 8 of the 16 factors compared between the two stocks.
Get Theratechnologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding THTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Theratechnologies Competitors List
Related Companies and Tools
